Jakob Bue Bjorner

13PUBLICATIONS
38CO-AUTHORS
Cross-sectional analysisProsthetics and orthoticsDisease surveillanceExercise physiologyGastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 11, 2026
Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

|Apr 29, 2025
Reliability and validity of the Transthyretin Amyloidosis - Quality of Life (ATTR-QOL) Questionnaire impact scales.

Andrew Lovley, Kristen Hsu, Kaitlin LaGasse

|Nov 27, 2024
Valuation survey for SF-6Dv2 in Japan based on the international protocol.

Takeru Shiroiwa, Yosuke Yamamoto, Tatsunori Murata

|May 03, 2024
Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials.

Domenica Rubino, Jakob B Bjorner, Naveen Rathor

|Apr 13, 2023
The improved health utility of once-weekly subcutaneous semaglutide 2.4 mg compared with placebo in the STEP 1-4 obesity trials.

Jakob Bue Bjorner, Sara Larsen, Christopher Lübker

|Jul 23, 2022
Establishing thresholds for meaningful within-individual change using longitudinal item response theory.

Jakob Bue Bjorner, Berend Terluin, Andrew Trigg

Pageof 3

Frequent Collaborators

3 joint publications

John Brazier

2 joint publications

John Browne

2 joint publications

Jacob Pedersen

2 joint publications

Tim Croudace